A: I was attracted to Inivata to help progress a technology I see can make a major impact in improving how we diagnose and manage patients with cancer. The field of liquid biopsy, and ctDNA analysis specifically, is undergoing rapid development and we’re only now...
Q: What were the motivations to create the Oncology Precision Network (OPeN)? A: As we began implementing precision oncology at our hospitals and clinics throughout Intermountain Healthcare, we quickly began to realize that there are certain variants or mutations in a patient’s tumor that we may...
Does Immunotherapy Measure Up to the Hype? Brigitte Ganter, PhD Disclosures | October 27, 2016 Editor’s Note: The emergence of immunotherapy has redefined cancer medicine. Among those who continue to redefine this expanding arena of clinical research, James P. Allison, PhD, of MD Anderson Cancer Center, holds a special place....
Dr. James Allison of MD Anderson Cancer Center, considered by many to be the “father of immunotherapy” is a recipient of the PMWC 2017 Pioneer Award. In his interview published earlier this week on Medscape highlighted some of the key focus areas of PMWC 2017...
Major Announcement - Medicare Makes Genetic Testing More Affordable and Accessible “Reimbursement policies threaten the development of molecular diagnostics as a critical element in making precision medicine a reality. The payors are beginning to feel the pressure for more responsive reimbursement policies but it is up...
In contrast to the three traditional pillars of cancer treatment (surgery, radiotherapy, and chemotherapy), cancer immunotherapy is a relatively young field, yet it is considered a huge game-changer - as it is in the process of changing how we treat cancer. Immunotherapy is rapidly becoming part...
Times couldn’t be more exciting with the ongoing conceptualization and implementation of Precision Medicine, the revolutionary approach to research, health, and healthcare that is continuously evolving, driven in part by the Precision Medicine Initiative launched and supported by President Obama; the recent NIH education boost...
Diagnostics is hugely influencing disease treatment, management,and interventional prevention. The flood of findings is enormous, yet, not all of it is interpretable which produces a huge challenge not only for the test provider, but also for the physician and patient. At the upcoming Personalized Medicine...
The development of technologies that allow the detection of circulating tumor cells, cell free DNA, or exosomes, combined with the advancements of sequencing technologies and the identification of novel biomarkers now allow more accurate detection and possible insights into the characteristics of malignant tumors than traditional biopsies...
The upcoming Personalized Medicine World Conference (PMWC) 2016 Silicon Valley will honor a few exceptional leaders whom have played, and continue to play, a tremendously critical role in shaping our healthcare system, changing it from a general population approach to a personalized and patient-centered care...
